Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.

TSXV:APC.H - Post Discussion

View:
Post by jmostock on Mar 01, 2021 5:23pm

Share price

Trying to determine if the rise in SP is real, we are currently in a market with all boats float.   The one main reason I think it's real is the PP announced today.   $1.25M is so much different than the usual $200K to keep lights on for another year.    Let's hope the son of Dr. Krantz is a savory businessman not just a scientist and maybe we are closer to a licensing agreement.    If we land one liecensing agreement, we'll be over a dollar in no time. jmo
Comment by Goldnboy1 on Mar 02, 2021 9:18pm
Even though today was quiet. Few sellers around. Pretty safe to say. Some real money trying to get long here.  The market these guys exist in is massive. Most in class price at 9-10 figure market caps.  This feels destined for greatness at these levels! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities